Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Colorcon
Moodys
AstraZeneca
McKesson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,242,003

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,242,003 protect, and when does it expire?

Patent 6,242,003 protects LESCOL XL and is included in one NDA.

Protection for LESCOL XL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-eight patent family members in nineteen countries.

Summary for Patent: 6,242,003
Title: Organic compounds
Abstract:An oral dosage form comprising fluvastatin and HPMC, which oral dosage form is color-stable upon prolonged periods of storage.
Inventor(s): Kalb; Oskar Michael (Loerrach, DE), Valazza; Stephen John (Matawan, NJ)
Assignee: Novartis AG (Basel, CH)
Application Number:09/549,222
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,242,003
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Use; Process;

Drugs Protected by US Patent 6,242,003

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis LESCOL XL fluvastatin sodium TABLET, EXTENDED RELEASE;ORAL 021192-001 Oct 6, 2000 AB RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Johnson and Johnson
Colorcon
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.